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Abstract
Background—The emergence of artesunate-mefloquine (AS+MQ)–resistant Plasmodium
falciparum in the Thailand-Cambodia region is a major concern for malaria control. Studies
indicate that copy number increase and key alleles in the pfmdr1 gene are associated with AS+MQ
resistance. In the present study, we investigated evidence for a selective sweep around pfmdr1
because of the spread of adaptive mutation and/or multiple copies of this gene in the P. falciparum
population in Cambodia.
Methods—We characterized 13 microsatellite loci flanking (± 99 kb) pfmdr1 in 93 single-clone
P. falciparum infections, of which 31 had multiple copies and 62 had a single copy of the pfmdr1
gene.
Results—Genetic analysis revealed no difference in the mean (± standard deviation) expected
heterozygosity (He) at loci around single (0.75 ± 0.03) and multiple (0.76 ± 0.04) copies of
pfmdr1. Evidence of genetic hitchhiking with the selective sweep of certain haplotypes was seen
around mutant (184F) pfmdr1 allele, irrespective of the copy number. There was an overall
reduction of 28% in mean He (± SD) around mutant allele (0.56 ± 0.05), compared with wild-type
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allele (0.84 ± 0.02). Significant linkage disequilibrium was also observed between the loci
flanking mutant pfmdr1 allele.
Conclusion—The 184F mutant allele is under selection, whereas amplification of pfmdr1 gene
in this population occurs on multiple genetic backgrounds.
The Thailand-Cambodia border has been an epicenter for drug-resistant malaria and is
where resistance to chloroquine (CQ) emerged in the early 1960s [1]. Sulfadoxine-
pyrimethamine (SP) officially became the first-line treatment for falciparum malaria in
1989, followed by mefloquine (MQ) in 1994, although both drugs were likely available in
the private sector much earlier. Resistance to MQ exceeded 25% (RI–RIII) in western
Cambodia in the mid-1990s, and artemisinin-based combination therapy (ACT) consisting
of artesunate (AS) and MQ, was adopted as the first-line treatment against Plasmodium
falciparum countrywide in 2000 [2]. There is growing evidence that efficacy of AS+MQ is
decreasing along the Thailand-Cambodia border [3–7], as well as in southwestern Cambodia
[8].
One of the most widely used molecular markers for predicting MQ or AS+MQ early
treatment failure and/or recrudescence is an increase in copy number in the pfmdr1 gene [3,
8–10]. The pfmdr1 gene amplification has been found to be associated with resistance to
MQ, AS, quinine (QN), and halofantrine (HAL) in in vitro–selected parasite lines [11–13]
and genetically modified parasites [14], as well as in clinical isolates [9, 15–18]. In addition
to gene amplification, pfmdr1 alleles 86N, 1034S, 1042N, and 1246D have also been
associated with in vitro resistance to MQ and AS in genetically modified parasite lines [19,
20] and clinical isolates [17, 21]. Field studies have also shown selection of the 86N allele in
recurrent infections after treatment with AS+MQ or artemether plus lumefantrine (AL) [9,
22–24], which suggests that 86N could be a potential marker of MQ and lumefantrine
resistance in vivo. However, no clear association between pfmdr1 184F mutation and MQ
failure has been established, although this allele is widespread in Cambodia [25]. Western
Cambodia has a higher prevalence of MQ resistance than does eastern Cambodia, and this is
consistent with an increased frequency of multiple copies of pfmdr1 and the 184F mutation
in the western part of the country, compared with the eastern part of the country [25, 26].
Although AS+MQ treatment policy for uncomplicated falciparum malaria applies for the
whole of Cambodia, the difference in drug pressure between western and eastern Cambodia
is well known. The available data indicate high efficacy (~100%) of AS+MQ in eastern
Cambodia, compared with Pailin in western Cambodia, where a reduced efficacy (79%) of
AS+MQ has been reported [6, 25].
Microsatellites are important markers to identify regions in the genome that have been under
selection. During the process of selection, a beneficial mutation spreads through the
population that results in a reduction of heterozygosity at both the selected locus and neutral
flanking microsatellite loci (genetic hitchhiking) [27]. Under continuous selection, the
mutation eventually gets fixed in the population, and sequence diversity is reduced around
the selected locus (selective sweep). Evidence of selective sweeps around drug-resistant
pfcrt and dhfr, dhps alleles due to CQ and SP drug pressure, respectively, have been
described in several P. falciparum populations [28–32]. Microsatellite analysis around these
alleles also revealed that CQ and SP resistance originated independently at only a few places
and later spread to other parts of the world, which suggests the role of gene flow in the
evolution of drug resistance [29, 30, 32–34]. Hence, it is important to investigate whether
evolving MQ resistance has a similar genetic basis.
Previous studies have addressed the genetic basis of pfmdr1 gene amplification and found
that the amplification involves a wide chromosomal region (up to 100 kb) and contains
multiple copies of the pfmdr1 gene [11, 15, 35]. Recently, these findings were further
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confirmed in P. falciparum isolates from the Thailand-Myanmar border, which showed that
a 15–49 kb region of the chromosome 5 is amplified and contains 2–4 copies of pfmdr1 [36].
It is not known whether the amplification of the pfmdr1 gene in Cambodian parasites is
similar.
Here, we have attempted to understand the nature of selective sweeps occurring around
pfmdr1 caused by the spread of adaptive mutation and/or multiple copies of this gene in the
P. falciparum population in Cambodia. This study also addresses geographical differences in
the pfmdr1 haplotype pattern between eastern and western Cambodia.
MATERIALS AND METHODS
Sample collection, DNA isolation, pfmdr1 genotyping, and copy number estimation
Clinical isolates of P. falciparum were collected from patients with uncomplicated
falciparum malaria from 4 sites across Cambodia: Pailin and Kampong Seila in western
Cambodia and Memut and Rattanakiri in eastern Cambodia, as described earlier [25]. The
location of the study sites and distribution of MQ resistance is shown in Figure 1.
Epidemiologically, malaria incidence is much lower in western Cambodia than it is in
eastern Cambodia. Eastern Cambodia is less developed, has a greater population of ethnic
minorities, and has a very poor public health system. In eastern Cambodia, local
transmission within villages is more common, and all age groups are affected. In western
Cambodia, malaria is more predominant among adults, who are usually occupationally
exposed in the jungles (ie, outside of their villages), than it is among other age groups.
This study was approved by the Institutional Review Boards of the Cambodia National
Ethics Committee for Health Research, the US Naval Medical Research Unit No.2 (Jakarta,
Indonesia), and the University of North Carolina at Chapel Hill (Chapel Hill, NC).Written
informed consent was obtained from each participant before blood samples were collected.
The patients were treated with AS+MQ in accordance with current national antimalarial
drug policy.
DNA was extracted from filter paper blood spots using QIAamp Mini kit (Qiagen). The
pfmdr1 copy number estimation and genotyping of pfmdr1 codons 86, 184, 1034, 1042, and
1246 was done previously using real-time polymerase chain reaction (PCR) [25]. These
coded DNA samples were sent to the Centers for Disease Control and Prevention laboratory
at Atlanta, Georgia, for further analysis. Of 158 DNA samples, 62 had multiple copies (≥2)
of pfmdr1, whereas the remaining 96 samples had single copies of pfmdr1 [25]. We also
performed direct sequencing of partial fragments of the pfmdr1 (for codons 86–184 and
1034–1246) on these samples to analyze any additional mutations. The pfmdr1 fragments
were amplified in 2 separate PCR reactions. The first fragment (~799 base pairs [bp])
covered codons 86–184 was amplified using AL6875F (5′-
CCGTTTAAATGTTTACCTGCAC-3′) and AL6876R (5′-
TGGGGTATTGATTCGTTGCAC-3′) primers with the following PCR cycling parameters:
initial denaturation at 94°C for 10 min, followed by 35 cycles of denaturation at 94°C for 1
min, annealing at 57°C for 1 min, extension at 72°C for 1 min, and a final extension at 72°C
for 10 min. The second fragment (~909 bp) that covered codons 1034–1246 was amplified
using AL6794F (5′-TATGCATACTGTTATTAATTATGG-3′) and AL6795R (5′-
TTCGATAAATTCATCTATAGCAG-3′) primers. The PCR cycling parameters for these
primers were also the same as for the first fragment, except that an annealing temperature of
56°C was used. The PCR product was sequenced on an ABI 3130xl Genetic Analyzer using
BigDye Terminator, version 3.1 (Applied Biosystems). The internal primers AL6877F (5′-
GTATGTGCTGTATTATCAGGAG-3′) and AL6878R (5′-
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AGCCTCTTCTATAATGGACATG-3′) were used to sequence the first fragment, whereas
the second fragment was sequenced using AL6794F and AL6795R primers.
Microsatellite allele scoring and statistical analysis
All 158 isolates were first assayed for 8 neutral microsatellite loci on chromosomes 2 and 3,
unlinked to any gene under selection [37]. Of 158 samples, 65 had multiple alleles at ≥1
neutral loci and thus were excluded from the study. The remaining 93 isolates were further
analyzed for 13 microsatellite loci (−99, −54, −29.5, −9.3, −4.2, and −3.3 kb upstream and
0, 0.16, 0.45, 3.6, 9.1, 23.3, 89 kb downstream) flanking the pfmdr1 gene on chromosome 5.
Primer sequences and PCR cycling parameters for all 8 neutral loci and 13 pfmdr1 loci have
been described elsewhere [31, 36, 37]. PCR products were separated on ABI 3130xl Genetic
Analyzer and analyzed using Gene-Mapper software, version 3.7 (Applied Biosystems).
The genetic variation at each locus was measured as expected heterozygosity (He) and
number of alleles per locus (A). He was calculated using the formula
, where n is the number of samples genotyped for that locus and
pi is the frequency of the ith allele. The Microsatellite ToolKit was used to compute He, pi as
well as A [38]. The sampling variance for He was calculated as
. The closest 8 loci (± 9 kb) around pfmdr1 (−9.3,
−4.2, −3.3, 0 [within gene], 0.16, 0.45, 3.6 and 9.1 kb) were used for grouping isolates or
parasites into haplotypes. The haplotypes were considered to be unique if they differed at
even 1 of the 8 loci analyzed.
Significant associations between pairs of loci were determined on the basis of an exact test
of linkage disequilibrium performed in Arlequin, version 3.01 [39]. To correct for multiple
testing, Bonferroni correction was used. The genetic differentiations between groups (single
copy vs multiple copies and wild-type [184Y] vs mutant [184F] alleles) were determined
through Wright’s fixation index (FST) using Arlequin, version 3.01 [39].
We used the same 8 loci (± 9 kb) to make a median-joining haplotypes network (Network,
version 4.5.1.0.) to predict the genetic relationship among the haplotypes. Median joining
networks are used for reconstructing the phylogeny of regions with reticulate evolution [40].
RESULTS
pfmdr1 Mutant alleles and copy number in Cambodia
We sequenced the pfmdr1 region covering codons 86–184 and 1034–1246 in Cambodian P.
falciparum isolates. We grouped the isolates from all 4 sites on the basis of whether they
harbored a single copy or multiple (≥2) copies of pfmdr1. Overall, the pfmdr1 sequencing
results for 93 isolates (from patients with single-clone infections) revealed that only a
minority (2.15%) contained mutations at codon 86 (86Y), whereas ~54% of the isolates
harbored a mutation at codon 184 (184F). None of the isolates contained mutation at codon
1246. Mutations at codons 1034 and 1042 were only observed in conjunction with mutation
at codon 184 (Table 1). Two major differences in the distribution of pfmdr1 alleles and copy
number were observed between isolates from western and eastern Cambodia. First, we
observed an unbiased distribution of 184F mutation in isolates from western Cambodia
(Pailin and Kampong Seila), where both isolates with a single copy and isolates with
multiple copies of pfmdr1 carried the 184F mutation. This was in striking contrast to the
eastern Cambodian (Memut and Rattanakiri) population, where the 184F mutation was
completely absent in isolates with multiple copies of pfmdr1. Second, the 86Y mutation and
the recently described mutations 130K and 1109I [41] were observed exclusively in the
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eastern population, albeit at low frequencies (3.5%, 3.5%, and 7.1%, respectively).
However, both populations contained the double mutant 184F plus 1042D, although this was
found exclusively in isolates that contained a single copy of pfmdr1.
Genetic variation at microsatellite loci flanking pfmdr1 and selective sweep of 184F allele
We attempted to study the genetic hitchhiking of flanking pfmdr1 loci resulting from the
spread of multiple copies of pfmdr1 and/or mutant 184F allele among these isolates. In this
regard, we compared the level of heterozygosity (He) and number of alleles per locus (A) on
the basis of single versus multiple copies of pfmdr1 and wild-type (184Y) versus mutant
(184F) groups (Figures 2 and 3 and Table 2). Overall, fewer alleles and less genetic diversity
were found in the loci surrounding pfmdr1 than were found in the neutral loci on
chromosomes 2 and 3 (Table 2). However, there were no obvious differences in the
heterozygosities for any of the 13 loci between samples with single copies and those with
multiple copies of pfmdr1. The single-copy and multiple-copy groups had almost identical
mean He values (± standard deviation [SD]) of 0.75 ± 0.03 and 0.76 ± 0.04, respectively
(Figure 2A and 2B). However, interpopulation analysis revealed markedly reduced He at
almost all of the loci in the western Cambodian population, compared with the eastern
Cambodian population (Figure 2C and 2D).
Interestingly, evidence of genetic hitchhiking was seen that was due to selective sweep of
184F pfmdr1 allele in the population. There was an overall reduction of 28% in mean He (±
SD) observed for the isolates carrying the 184F allele (0.56 ± 0.05), compared with those
harboring the wild-type 184Y allele (0.84 ± 0.02) (Figure 3A and 3B and Table 2). The
difference in He between wild-type (0.86) and mutant (0.53) alleles was greater (33%
reduction) in the upstream region of pfmdr1. On the other hand, the difference in He
between wild-type (0.82) and mutant (0.60) alleles was relatively less (22% reduction) in the
downstream region (Figure 3A). To investigate the role of 184F-driven selective sweep, we
compared the heterozygosities around the 184Y and 184F alleles in isolates from eastern
Cambodia. The results revealed a reduction in heterozygosity around 184F, compared with
the wild-type allele, in the eastern Cambodian population (Figure 3C and 3D). The reduction
around the 184F allele was greater in the isolates from western Cambodia (Figure 3C and
3D). We could not compare heterozygosities around the 184Y allele in western Cambodia,
because there were only 4 isolates that harbored this allele.
Linkage disequilibrium between loci flanking pfmdr1
The pattern of linkage disequilibrium was also deduced to explore the extent of 184F-
induced selective sweeps operating in the population. The pair-wise linkage disequilibrium
distribution between the closest (± 9 kb) pfmdr1 microsatellite loci is shown in Figure 4.
Significant linkage disequilibrium was observed between loci close to pfmdr1 in the group
with the mutant 184F allele, but no association was observed between loci in the group with
the 184Y allele (Figure 4A). On the other hand, we found significant linkage disequilibrium
between these loci in both groups with single or multiple copies of the pfmdr1 gene (Figure
4B).
Genetic differentiation and relationships among pfmdr1 microsatellite haplotypes
The genetic differentiation between the 184Y (wild-type) and 184F (mutant) groups using
the closest 8 microsatellite loci (± 9 kb) around the pfmdr1 gene was measured employing
Wright’s fixation index, FST. Significant FST (FST, 0.03; P < .001) was observed between
the wild-type (184Y) and mutant (184F) groups, as would be expected because of the
decrease in genetic diversity within this subpopulation. Unsurprisingly, a low but
insignificant level of genetic differentiation was observed between subpopulations with a
single copy and those with multiple copies of pfmdr1 (FST, 0.003; P > .05).
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The same 8 loci (± 9 kb) were also used for classifying the 93 isolates into 66 haplotypes
(H1–H66) (Figure 5). When we looked at the distribution of haplotypes irrespective of
pfmdr1 copy number by geography, we found fewer haplotypes in western Cambodia (19
haplotypes among 37 isolates) than in eastern Cambodia (51 haplotypes among 56 isolates),
which suggests less genetic diversity in western Cambodia. Only 4 haplotypes (H1, H8, H9,
and H12) were shared between eastern and western isolates, including isolates that bore a
single copy and those that bore multiple copies of pfmdr1 (Figure 5). Overall, the
subpopulation with multiple copies of pfmdr1 displayed a relatively smaller number of
haplotypes (27) than did the subpopulation with single copies (45) (Figure 5). Only 6
haplotypes (H1, H2, H3, H5, H8, and H9) were shared by subpopulations with both single
and multiple pfmdr1 copies, and all of them had the pfmdr1 184F mutation (Figure 5). We
also found that wild-type and mutant pfmdr1 alleles did not share any microsatellite
haplotypes. The haplotypes with the mutant 184F allele (on genetic backgrounds of both
single and multiple pfmdr1 copies) were found to form 3 main independent clusters (Figure
5).
DISCUSSION
Resistance to AS+MQ has developed on the Thailand–Cambodia border. This study
provides comprehensive data on the distribution of pfmdr1 alleles and the pattern of
selective sweeps in 4 sites in Cambodia with different levels of transmission and different
drug resistance profiles. As has been shown elsewhere [25], our results from pfmdr1
sequencing also confirmed the high prevalence (~86%) of the 184F allele in western
Cambodia (Table 1), where a significant level of MQ resistance has been reported. On the
other hand, the prevalence of 184F allele in eastern Cambodia was low (~32%), which also
correlates with the reduced level of MQ resistance in this region (Table 1). In western
Cambodia, the pfmdr1 amplification was found to occur on both 184Y and 184F
backgrounds, in contrast with eastern Cambodia, where all of the amplification was found
on the 184Y background (Table 1). A possible explanation for this is that the pfmdr1
amplification is independent of the acquisition of the 184F mutation by the parasites.
Although an increased copy number in the pfmdr1 gene has been associated with MQ
resistance, the significance of the 184F mutation remains less well understood [9, 42]. A
study on the Southeast Asian P. falciparum population showed that isolates that fall under
category I (all wild-type pfmdr1 codons: 86N, 184Y, 1034S, and 1042N) and category III
(mutation at only 184 codon: 86N, 184F, 1034S, and 1042N) exhibited increased resistance
to MQ and AS [17]. Also, the isolates with amplified pfmdr1 fell into category I or III and
were significantly more resistant to these drugs. A recent study from Cambodia
demonstrated that isolates with single 184F mutation had a significantly elevated 50%
inhibitory concentration for MQ [41]. Similar results were obtained in studies from Tanzania
and Uganda, where treatment with another widely used ACT (AL) selected for reinfecting
parasites with 86N, 184F, and 1246D pfmdr1 alleles [24, 43, 44]. The wild-type 86N allele
has been found to be associated with increased 50% inhibitory concentrations to MQ and AS
[9, 18, 42, 45].
We characterized microsatellites flanking (± 99 kb) the pfmdr1 gene to estimate the strength
of genetic hitchhiking resulting from the spread of the 184F mutant allele and/or
amplification events in pfmdr1. As evident from Figure 3, 184F mutant allele appears to be
under strong selection with reduced variation spanning from 99 kb upstream to 88 kb
downstream of the gene. Generally, downstream loci exhibited a lower reduction in He,
except at the 0.45-kb locus, where we found a sharp reduction of 57%, compared with wild-
type pfmdr1 (Table 2 and Figure 3). We could not find in the PlasmoDB any other potential
gene under selection around this locus that could be responsible for such a sharp reduction in
He. Present data seems to suggest that the 184F allele has undergone a selective sweep, but it
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is not clear whether MQ or other drug pressure is the cause for this selection. Although a
previous study by Nair et al [36] reported that a significant proportion (30%; n = 326) of the
Thailand isolates harbor the 184F allele, the authors did not mention any genetic hitchhiking
resulting from the spread of this allele.
Amplification of the pfmdr1 gene was found to occur on multiple haplotype backgrounds
based on the typing of 13 microsatellite loci (Figure 5). Our observation indicating multiple
origins for the development of strains with multiple copies of pfmdr1 in Cambodia is in
agreement with previous observations in Thailand and other studies [35, 36]. Nair et al [36]
have described a “soft selective sweep” in the isolates with multiple copies of pfmdr1 from
the border of Thailand and Myanmar. They have shown a “limited” reduction (~42%; range,
21%–63%) in heterozygosities in the 16 loci surrounding (± 18 kb) pfmdr1 in isolates
bearing multiple copies, compared with those carrying a single copy. Our results are also
consistent with the soft selective sweep model, because it is evident that putatively
advantageous alleles with multiple copies of pfmdr1 have entered the population recurrently
(Figure 5). Thus, we may not have detected a decrease in heterozygosity simply because the
strength of that pattern is affected by the number and neutral divergence among adaptive
equivalent alleles [46]. The amplification of pfmdr1 has been suggested to be a frequent
event, and an increase from a single-copy state to having 2 copies of pfmdr1 has been found
to occur in every 108 parasites [47]. The rate of occurrence of gene duplication is much
higher than that of mutation within codons, which occurs at a much lower frequency
(1:1014) [48]. In the presence of MQ drug pressure, an increase in pfmdr1 copy number has
been observed, whereas deamplification occurs under CQ pressure in laboratory isolates
[12–14, 49].
We attempted to study the genetic relationships among haplotypes using Network to
visualize whether the multiple pfmdr1 copy–bearing haplotype emerged from the single-
copy haplotype (Figure 5). Indeed, the multiple pfmdr1 copy group was found to share some
haplotypes with the single-copy group. Possible explanations for not finding the progenitor
haplotype from which single or multiple pfmdr1 copies may have emerged in our sample set
could be attributable to a recent selective sweep (ie, not enough time has passed to detect
selective changes) or attributable to recurring pfmdr1 copy number changes that promote
duplication events on multiple genetic backgrounds. The negligible FST value and similarity
between the amount of linkage disequilibrium between single and multiple pfmdr1 copy
sub-populations suggests that the frequency of duplication events is independent of the
genetic background. Other studies similarly suggest multiple and independent origins of
pfmdr1 gene amplification [15, 35, 36].
In conclusion, this study provides evidence that rapid changes in pfmdr1 copy number are
evolving on multiple genetic backgrounds. It remains to be seen whether the amplified
pfmdr1 gene will spread in the population as rapidly as CQ-and SP-resistant genotypes. The
184F allele appears to be under selective pressure, but it remains to be established to what
extent this mutation influences resistance to MQ. Moreover, it will be important to monitor
whether the dissemination of the 184F could also assist in spreading strains with multiple
copies of the pfmdr1 gene in the population. Therefore, continuing molecular surveillance
using genetic markers may help track the spread of MQ resistant parasites and allow better
containment of MQ resistance.
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A map of Cambodia showing the location of the 4 sites (Pailin, Kampong Seila, Memut, and
Rattanakiri) from which the isolates used in this study were obtained. The proportion of
mefloquine (MQ) resistance in Cambodia and bordering areas (Thailand to the west,
Vietnam to the east, and Laos to the north) is indicated by pie charts.
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The expected heterozygosity (He) at 13 microsatellite loci around pfmdr1. Comparison of He
between groups of isolates with a single copy or multiple copies of pfmdr1. The mean He at
neutral loci on chromosomes 2 and 3 is shown by a dotted line. The error bars indicate ± 1
standard deviation. A, isolates from both western and eastern Cambodia; B, detail showing
the closest 8 microsatellite loci flanking (± 9 kb) pfmdr1 for isolates from western and
eastern Cambodia; C, isolates from western Cambodia; D, isolates from eastern Cambodia.
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The expected heterozygosity (He) at 13 loci around wild-type (184Y) and mutant (184F)
pfmdr1. Comparison of He between 184Y and 184F pfmdr1 groups of isolates from both
western and eastern Cambodia (A) and the closest 8 microsatellite loci flanking (± 9 kb)
pfmdr1 (B), and comparison of 184F group of isolates from western Cambodia with 184F
and 184Y groups of isolates from eastern Cambodia (C) and the closest 8 microsatellite loci
flanking (± 9 kb) pfmdr1 (D). The mean He at neutral loci on chromosomes 2 and 3 is shown
by a dotted line. The error bars indicate ± 1 standard deviation.
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Pair-wise linkage disequilibrium around pfmdr1 (± 9 kb). A, linkage disequilibrium between
loci within the wild-type group (lower half of the diagonal) and mutant group (upper half of
the diagonal). B, linkage disequilibrium between loci within the group of isolates with a
single copy of pfmdr1 (lower half of the diagonal) and those with multiple copies of pfmdr1
(upper half of the diagonal). Each cell shows a comparison between polymorphic pairs of
loci. P < .006 was considered to be significant after Bonferroni correction. Light gray cells
represent P values that are not significant (>.006), and dark gray cells indicate statistically
significant P values (<.006).
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Median-joining network showing genetic relationships among pfmdr1 haplotypes in
Cambodia. The closest 8 loci (± 9 kb) were used for constructing the network. Each circle in
this network represents a unique haplotype, with the size of the circle being proportional to
the number of isolates harboring that haplotype. The circles shown in yellow and gray
represent isolates carrying single and multiple copies of pfmdr1, respectively. The haplotype
shared by both isolates with single and isolates with multiple pfmdr1 copies (proportion
indicated in pie charts) are shown as a circle with both yellow and gray shading. The red
dots are the median vectors that imply software-generated “hypothetical haplotypes,” joining
2 haplotypes in the diagram from which single and/or multiple pfmdr1 copy–containing
haplotypes may have originated. The isolates with 184F are marked by blue arrows enclosed
in the shaded clusters.
Vinayak et al. Page 15




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































J Infect Dis. Author manuscript; available in PMC 2011 May 17.
